Neonatal BCG vaccination and atopic dermatitis before 13 months of age: A randomized clinical trial

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 73, Issue 2, 2018, Pages 498-504

  Thostesen L M ^a   Kjaergaard J ^b   Pihl, G T ^a   Birk, N M ^c   Nissen, T N ^c   Aaby, P ^d   Jensen, A K G ^e   Olesen, A W ^f   Stensballe, L G ^b   Jeppesen, D L ^c   Benn, C S ^f,g   Kofoed, P E ^a  

^a KOLDING HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d Bandim Health Project   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

atopic dermatitis; Bacillus Calmette Gu rin; heterologous immunity; infants; randomized controlled trial

Indexed keywords

BCG VACCINE;

ARTICLE; ATOPIC DERMATITIS; BCG VACCINATION; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HIGH INCOME COUNTRY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; INFANT; NETHERLANDS;

BCG VACCINE; DERMATITIS, ATOPIC; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NETHERLANDS;

EID: 85031087157     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.13314     Document Type: Article

References (20)

1. Thomsen SF. Epidemiology and natural history of atopic diseases. Eur Clin Respir J. 2015;2:24642.
2. Roy A, Eisenhut M, Harris RJ, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ. 2014;349:g4643.
3. Arnoldussen DL, Linehan M, Sheikh A. BCG vaccination and allergy: a systematic review and meta-analysis. J Allergy Clin Immunol. 2011;127:246-253.
4. Linehan MF, Nurmatov U, Frank TL, Niven RM, Baxter DN, Sheikh A. Does BCG vaccination protect against childhood asthma? Final results from the Manchester Community Asthma Study retrospective cohort study and updated systematic review and meta-analysis. J Allergy Clin Immunol. 2014;133:688-695.
5. Steenhuis TJ, van Aalderen WM, Bloksma N, et al. Bacille-Calmette-Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single-blind study. Clin Exp Allergy. 2008;38:79-85.
6. Thostesen LM, Nissen TN, Kjaergaard J, et al. Bacillus Calmette-Guerin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trial. Contemp Clin Trials. 2015;42:213-218.
7. Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol. 2007;157:645-648.
8. Aaby P, Roth A, Ravn H, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infectious Dis. 2011;204:245-252.
9. Aaby P, Vessari H, Nielsen J, et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr Infect Dis J. 2006;25:721-727.
10. Aaby P, Martins CL, Garly ML, et al. Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival. Clin Infect Dis. 2014;59:484-492.
11. Stensballe LG, Sorup S, Aaby P, et al. BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial. Arch Dis Child. 2017;102:224-231.
12. Johnke H, Vach W, Norberg LA, Bindslev-Jensen C, Host A, Andersen KE. A comparison between criteria for diagnosing atopic eczema in infants. Br J Dermatol. 2005;153:352-358.
13. Engebretsen KA, Bager P, Wohlfahrt J, et al. Prevalence of atopic dermatitis in infants by domestic water hardness and season of birth. J Allergy Clin Immunol. 2017;139:1568-1574.
14. Gruber C, Meinlschmidt G, Bergmann R, Wahn U, Stark K. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr Allergy Immunol. 2002;13:177-181.
15. Marks GB, Ng K, Zhou J, et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol. 2003;111:541-549.
16. Flohr C, Nagel G, Weinmayr G, et al. Tuberculosis, bacillus Calmette-Guerin vaccination, and allergic disease: findings from the International Study of Asthma and Allergies in Childhood Phase Two. Pediatr Allergy Immunol. 2012;23:324-331.
17. Mawa PA, Webb EL, Filali-Mouhim A, et al. Maternal BCG scar is associated with increased infant proinflammatory immune responses. Vaccine. 2017;35:273-282.
18. Thostesen LM, Stensballe LG, Pihl GT, et al. Neonatal BCG vaccination has no effect on recurrent wheeze in the first year of life: a randomized clinical trial. J Allergy Clin Immunol. 2017;140:1616-1621.
19. Thostesen LM, Kjaer HF, Pihl GT, et al. Neonatal BCG has no effect on allergic sensitization and suspected food allergy until 13 months. Pediatr Allergy Immunol. 2017;28:588-596.
20. Nissen TN, Birk NM, Kjaergaard J, et al. Adverse reactions to the Bacillus Calmette-Guerin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial. Vaccine. 2016;34:2477-2482.